We’ve all heard of Ozempic by now. It’s only licensed for use as an injectable diabetes treatment in the UK and US, but it’s widely used ‘off label’ to help people lose weight. So much so in fact, tha

MULTIPLYING WEIGHT-LOSS MEDS WHEN MIKE DOUSTDAR STARTED AS A SUMMER EMPLOYEE making copies at Novo Nordisk—a teenager living in Austria after fleeing unrest in his home country of Iran at 12—he never

Around 2.5 million people are currently taking weight-loss drugs in the UK. That’s almost 3.5% of the population injecting drugs such as Mounjaro and WeGovy and facing up to access barriers, price fluctuations and supply shortages. But, as four men explain, the hype around these drugs is very real

It wasn’t just me feeling lighter, my purse was too

From personalised treatments to new AI-powered tools, diabetes care is undergoing a revolution. We explain how to make recent developments work for you

Centrica focuses on investment: Lower energy prices weighed on Centrica’s full-year earnings for 2025, which fell 40% from a year earlier, says Rachel Millard in the Financial Times. The owner of Brit